| 图片 | 名称及描述 | |
|---|---|---|
|
Polatuzumab
97%
|
||
|
PI3K-IN-30
97%
|
||
|
PROTAC FAK degrader 1
97%
|
||
|
PAC1R antagonist 1
97%
|
||
|
phenyl(piperidin-3-yl)methanol
97%
|
||
|
PKD-IN-1 dihydrochloride
97%
|
||
|
PROTAC BRD4 ligand-1
98%
|
||
|
Protein kinase inhibitors 1 hydrochloride
97%
|
||
|
PI3Kα-IN-4
97%
|
||
|
piperidine-4-boronic acid pinacol ester HCl
97%
|
||
|
PYIMRQWQFOYRSI-UHFFFAOYSA-N
97%
|
||
|
Phenol, 4-[6-(1,1-dimethylethoxy)-3,4-dihydro-1-naphthalenyl]-
97%
|
||
|
Propanamide, 3-chloro-N-(3-cyanophenyl)-2,2-dimethyl-
97%
|
||
|
PARP/PI3K-IN-1
97%
|
||
|
Phen Green SK diacetate (5/6-mixture)
97%
|
||
|
Piperazine, 1-[(2-chloro-5-thiazolyl)methyl]-4-(phenylmethyl)-
97%
|
||
|
Penpulimab
97%
|
||
|
Pomalidomide-C2-amido-(C1-O-C5-O-C1)2-COOH
97%
|
||
|
Pomalidomide-amido-C1-Br
97%
|
||
|
PHOSPHINOUS AMIDE, N,N-BIS(1-METHYLETHYL)-P,P-DIPHENYL-
97%
|

